Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 4/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | CBS | P35520 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9106098 | 0.84 | ACHE (0.50) | ACHECYP3A4HSP90AB1LTA4HCBS | |
| SCHEMBL2336642 | 0.84 | IDO1 (0.41) | ERN1IDO1MAOAMAOB | |
| SCHEMBL13978619 | 0.81 | XDH (0.44) | ACHEIDO1CYP3A4 | |
| SCHEMBL24197597 | 0.75 | KDM4E (0.32) | ERN1TDP1 | |
| SCHEMBL200104 | 0.75 | ACHE (0.67) | ACHEIDO1CYP3A4TSHRTDP1 | |
| SCHEMBL4469238 | 0.75 | ACHE (0.40) | ACHEIDO1CYP3A4TSHRTDP1 | |
| SCHEMBL20242292 | 0.74 | TACR1 (0.38) | ERN1IDO1 | |
| SCHEMBL2316019 | 0.74 | ACHE (0.36) | ACHETDP1HSP90AB1LTA4HCBS | |
| SCHEMBL13492226 | 0.74 | GPR84 (0.39) | ACHECYP3A4TSHRTDP1HSP90AB1 | |
| SCHEMBL3396094 | 0.74 | AKR1B1 (0.33) | IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008008059-A1 | ANTI-CANCER AGENTS ANS USES THEREOF | LOCUS PHARMACEUTICALS, INC. (US) | 2008-01-17 | — | — | WO | disclosed |